VNVladimir Novotny

Vladimir Novotny

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vladimir Novotny has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Manfred P. Wirth

    Department of Urology University Hospital 'Carl Gustav Carus' Technische Universität Dresden Fetscherstrasse 74 DE-01307 Dresden Germany

    4 shared publications
  • Rainer Koch

    Departments of a Urology Medical Statistics and Biometry 'Carl Gustav Carus' Technical University Dresden Dresden Germany

    3 shared publications
  • Stefan Zastrow

    Department of Urology University Hospital 'Carl Gustav Carus' Technische Universität Dresden Fetscherstrasse 74 DE-01307 Dresden Germany

    3 shared publications
  • Michael Froehner

    Department of Urology University Hospital 'Carl Gustav Carus' Technische Universität Dresden Fetscherstrasse 74 DE-01307 Dresden Germany

    2 shared publications
  • Ulrike Heberling

    Department of Urology, University Hospital "Carl Gustav Carus", Technical University Dresden, Fetscherstrasse 74, 01307, Dresden, Germany

    2 shared publications
  • Diana Wiessner

    1 shared publication

Latest Publications

  • Open Access

    Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer

    by Vladimir Novotny, Michael Froehner, Johanna Ollig, Rainer Koch, Stefan Zastrow, Manfred P. Wirth

    Purpose: To evaluate the impact of adjuvant intravesical bacillus Calmette-Guérin (BCG) treatment in patients with high-grade transitional cell carcinoma of bladder. Patients and Methods: A total of 207 consecutive patients who underwent transurethral resection for high-grade T1 transitional cell carcinoma of bladder at our institution between January 1, 2005 and December 31, 2012. Of those patients, 77 underwent early cystectomy without BCG instillation and were excluded from the analysis. The overall survival and cancer-specific mortality were compared in 2 different therapy options groups (group of patients who received adjuvant BCG instillation vs. the group of patients who did not receive BCG therapy). Overall mortality was estimated by the Kaplan-Meier method, univariate comparisons were made with the log rank test. The cumulative incidence of deaths from bladder cancer (BC) was determined by univariate and multivariate competing risk analysis. Cox proportional hazard models for competing risks were used to study the combined effects of the variables on BC-specific mortality. Results: The 5-year overall survival in patients with BCG instillation vs. patients who did not receive BCG therapy was 74 vs. 28% (p = 0.0016). In the univariate analysis, the adjuvant intravesical BCG treatment was associated with decreased cancer-specific mortality (p = 0.0062). In the multivariable analysis, the age and the BCG instillation were independent factors of overall survival (hazard ratio 0.26, 95% CI 0.15-0.46, p < 0.0001) and cancer-specific mortality (hazard ratio 0.29, 95% CI 0.12-0.71, p = 0.0067). Conclusion: Dispensing from adjuvant intravesical BCG treatment is associated with increased overall- and disease-specific mortality in patients with T1 high-grade transitional cell carcinoma of bladder. This observation confirms that adjuvant BCG instillation is a crucial part of treatment in this patient population.


  • Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy

    by Vladimir Novotny, Michael Froehner, Rainer Koch, Stefan Zastrow, Ulrike Heberling, Steffen Leike, Matthias Hübler, Manfred P. Wirth

    Radical cystectomy (RC) is a major surgical procedure accompanied with meaningful complications and countable perioperative mortality. To identify the risk factors predicting the perioperative morbidity and mortality is essential. The study aimed to identify relevant, patient-specific factors associated with 90-day mortality following RC, which may serve as a foundation for improving healthcare delivery to patients with bladder cancer.


  • Open Access

    Lee mortality index as comorbidity measure in patients undergoing radical cystectomy

    by Michael Froehner, Rainer Koch, Vladimir Novotny, Ulrike Heberling, Stefan Propping, Rainer J Litz, Matthias Hübler, Gustavo B Baretton, Oliver W Hakenberg, Manfred P Wirth

    To investigate the recently described Lee mortality index as predictor of mortality after radical cystectomy. A total of 735 patients who underwent radical cystectomy for bladder cancer between 1993 and 2010 were studied. Median patient age was 67 years and the median follow-up was 7.8 years (censored patients). The Lee mortality index was assigned based on data derived from patient history, preoperative cardiopulmonary risk assessment and discharge records. The age-adjusted Charlson score and preoperative cardiopulmonary risk assessment classifications were used for comparison. Competing risk analysis and Cox proportional hazard models for competing risks were used for the statistical analysis. The Lee mortality index predicted competing mortality in a dose–response relationship with somewhat lower 10-year mortality rates than predicted (p = 0.0120). Beside the age-adjusted Charlson score, the Lee mortality index was an independent predictor of overall mortality (hazard ratio per unit increase 1.06, p = 0.0415) and replaced the age-adjusted Charlson score as predictor of competing mortality (hazard ratio (HR) per unit increase 1.27, p < 0.0001). The American Society of Anesthesiologists (ASA) physical status classification was also an independent predictor of overall (HR for ASA 3–4 versus 1–2: 1.53, p = 0.0002) and competing mortality (HR for ASA 3–4 versus 1–2: 1.62, p = 0.0044). The Lee mortality index is a promising and easily applicable tool to predict competing mortality after radical cystectomy. It is at least equal to the age-adjusted Charlson score and may be supplemented by information provided by the ASA classification.


  • Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality

    by Vladimir Novotny, Stefan Zastrow, Rainer Koch, Manfred P. Wirth

    To analyze the impact of comorbidity on the perioperative complication rate after radical cystectomy in patients over 70 year of age. Between April 1993 and August 2010, 830 radical cystectomies were performed at our institution. Of the 830 patients, 365 patients (44.0%) were ≥70-year-old (median age 74 year). This group of elderly patients was compared with a younger group of 465 patients (56.0% of the whole cohort) aged under 70 year (median 63 year). The group of elderly patients had a significantly higher prevalence of concomitant diseases e.g., hypertension (57.3% vs. 38.5%), coronary heart disease (27.1% vs. 14.8%) and diabetes (25.5% vs. 14.6%). Perioperative complications were significantly more frequent in the elderly group: 31.0% versus 21.5% overall complication rate, P = 0.002. Mortality rate was almost similar in both groups: 0.6% (elderly) versus 0.5% (younger). Within the elderly group, the overall complication rate was significantly higher in patients with an ASA score ≥3 (37.0%) than in patients with an ASA score ≤2 (25.0%) (P < 0.02). Multivariate logistic regression analysis was used to identify that chronic obstructive lung disease, ASA score and age were independent predictive factors for perioperative complications. Elderly patients have a higher prevalence of concomitant systemic diseases. Some concomitant diseases can affect surgical outcome after radical cystectomy, particularly the frequency and character of perioperative complications. It is therefore of paramount importance to conduct a comorbidity assessment and preoperative conditioning of each patient, with a special focus on the patient’s individual risk factors and age.


  • Perioperative Complications of Radical Cystectomy in a Contemporary Series

    by Vladimir Novotny, Oliver W. Hakenberg, Diana Wiessner, Ulrike Heberling, Rainer J. Litz, Sven Oehlschlaeger, Manfred P. Wirth